Skip to main content

Chinese biopharma stocks jump as U.S. weighs keeping door open to drug deals

Chinese biopharma stocks rose on Monday after a report that the U.S. may continue to allow most drug licensing deals with Chinese firms

Read full article at CNBC

Originally published by CNBC. Summary and curation by DutyStation News.

📰 Related Stories

📰 General

Oil falls as crude flows remain 'surprisingly strong'

CNBC3h ago
📰 General

Here are the 3 big things we're watching in the stock market this week

CNBC6h ago
Android 17 QPR1 changes some Pixel status bar icons
📰 General

Android 17 QPR1 changes some Pixel status bar icons

9to5Google8h ago
No Dogs in Space is back to feed your need for obsessive music history
📰 General

No Dogs in Space is back to feed your need for obsessive music history

The Verge9h ago
📰 General

World model companies are keeping a lot of secrets

TechCrunch9h ago
📰 General

Elon Musk’s latest Boring Company pitch involves a Hyperloop between Austin and San Antonio

TechCrunch10h ago
← Back to News